A citation-based method for searching scientific literature

Kerry J Savage, Nancy Lee Harris, Julie M Vose, Fred Ullrich, Elaine S Jaffe, Joseph M Connors, Lisa Rimsza, Stefano A Pileri, Mukesh Chhanabhai, Randy D Gascoyne, James O Armitage, Dennis D Weisenburger. Blood 2008
Times Cited: 579







List of co-cited articles
742 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial.
Steven Horwitz, Owen A O'Connor, Barbara Pro, Tim Illidge, Michelle Fanale, Ranjana Advani, Nancy L Bartlett, Jacob Haaber Christensen, Franck Morschhauser, Eva Domingo-Domenech,[...]. Lancet 2019
331
42


ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.
Edgardo R Parrilla Castellar, Elaine S Jaffe, Jonathan W Said, Steven H Swerdlow, Rhett P Ketterling, Ryan A Knudson, Jagmohan S Sidhu, Eric D Hsi, Shridevi Karikehalli, Liuyan Jiang,[...]. Blood 2014
260
37

The 2016 revision of the World Health Organization classification of lymphoid neoplasms.
Steven H Swerdlow, Elias Campo, Stefano A Pileri, Nancy Lee Harris, Harald Stein, Reiner Siebert, Ranjana Advani, Michele Ghielmini, Gilles A Salles, Andrew D Zelenetz,[...]. Blood 2016
30


Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group.
Norbert Schmitz, Lorenz Trümper, Marita Ziepert, Maike Nickelsen, Anthony D Ho, Bernd Metzner, Norma Peter, Markus Loeffler, Andreas Rosenwald, Michael Pfreundschuh. Blood 2010
373
25

Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte trials.
David Sibon, Marion Fournier, Josette Brière, Laurence Lamant, Corinne Haioun, Bertrand Coiffier, Serge Bologna, Pierre Morel, Jean Gabarre, Olivier Hermine,[...]. J Clin Oncol 2012
120
23

Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01.
Francesco d'Amore, Thomas Relander, Grete F Lauritzsen, Esa Jantunen, Hans Hagberg, Harald Anderson, Harald Holte, Anders Österborg, Mats Merup, Peter Brown,[...]. J Clin Oncol 2012
371
20

Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma.
Ramona Crescenzo, Francesco Abate, Elena Lasorsa, Fabrizio Tabbo', Marcello Gaudiano, Nicoletta Chiesa, Filomena Di Giacomo, Elisa Spaccarotella, Luigi Barbarossa, Elisabetta Ercole,[...]. Cancer Cell 2015
293
17

Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma.
Barbara Pro, Ranjana Advani, Pauline Brice, Nancy L Bartlett, Joseph D Rosenblatt, Tim Illidge, Jeffrey Matous, Radhakrishnan Ramchandren, Michelle Fanale, Joseph M Connors,[...]. Blood 2017
117
17

Objective responses in relapsed T-cell lymphomas with single-agent brentuximab vedotin.
Steven M Horwitz, Ranjana H Advani, Nancy L Bartlett, Eric D Jacobsen, Jeff P Sharman, Owen A O'Connor, Tanya Siddiqi, Dana A Kennedy, Yasuhiro Oki. Blood 2014
218
16

Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project.
Dennis D Weisenburger, Kerry J Savage, Nancy Lee Harris, Randy D Gascoyne, Elaine S Jaffe, Kenneth A MacLennan, Thomas Rüdiger, Stefano Pileri, Shigeo Nakamura, Bharat Nathwani,[...]. Blood 2011
276
16

Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study.
Barbara Pro, Ranjana Advani, Pauline Brice, Nancy L Bartlett, Joseph D Rosenblatt, Tim Illidge, Jeffrey Matous, Radhakrishnan Ramchandren, Michelle Fanale, Joseph M Connors,[...]. J Clin Oncol 2012
689
15

Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study.
Owen A O'Connor, Steven Horwitz, Tamás Masszi, Achiel Van Hoof, Peter Brown, Jeannette Doorduijn, Georg Hess, Wojciech Jurczak, Poul Knoblauch, Shanta Chawla,[...]. J Clin Oncol 2015
281
14

Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy.
Bertrand Coiffier, Barbara Pro, H Miles Prince, Francine Foss, Lubomir Sokol, Matthew Greenwood, Dolores Caballero, Peter Borchmann, Franck Morschhauser, Martin Wilhelm,[...]. J Clin Oncol 2012
444
14


Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma.
Greg Hapgood, Susana Ben-Neriah, Anja Mottok, Derrick G Lee, Kridel Robert, Diego Villa, Laurie H Sehn, Joseph M Connors, Randy D Gascoyne, Andrew L Feldman,[...]. Br J Haematol 2019
35
40

DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study.
Martin Bjerregård Pedersen, Stephen Jacques Hamilton-Dutoit, Knud Bendix, Rhett P Ketterling, Patrick P Bedroske, Ivy M Luoma, Christopher A Sattler, Rebecca L Boddicker, N Nora Bennani, Peter Nørgaard,[...]. Blood 2017
74
17

Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors.
Vivien Mak, Jeremey Hamm, Mukesh Chhanabhai, Tamara Shenkier, Richard Klasa, Laurie H Sehn, Diego Villa, Randy D Gascoyne, Joseph M Connors, Kerry J Savage. J Clin Oncol 2013
271
13

Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements.
Rebecca L King, Linda N Dao, Ellen D McPhail, Elaine S Jaffe, Jonathan Said, Steven H Swerdlow, Christopher A Sattler, Rhett P Ketterling, Jagmohan S Sidhu, Eric D Hsi,[...]. Am J Surg Pathol 2016
63
20

CD30 expression in peripheral T-cell lymphomas.
Elena Sabattini, Marco Pizzi, Valentina Tabanelli, Pamela Baldin, Carlo Sagramoso Sacchetti, Claudio Agostinelli, Pier Luigi Zinzani, Stefano A Pileri. Haematologica 2013
87
13

Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directions.
C A van der Weyden, S A Pileri, A L Feldman, J Whisstock, H M Prince. Blood Cancer J 2017
109
12

ALK-positive anaplastic large-cell lymphoma in adults: an individual patient data pooled analysis of 263 patients.
David Sibon, Dinh-Phong Nguyen, Norbert Schmitz, Ritsuro Suzuki, Andrew L Feldman, Rémy Gressin, Laurence Lamant, Dennis D Weisenburger, Andreas Rosenwald, Shigeo Nakamura,[...]. Haematologica 2019
23
52

Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study.
Owen A O'Connor, Barbara Pro, Lauren Pinter-Brown, Nancy Bartlett, Leslie Popplewell, Bertrand Coiffier, Mary Jo Lechowicz, Kerry J Savage, Andrei R Shustov, Christian Gisselbrecht,[...]. J Clin Oncol 2011
419
12

Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study.
Peter Reimer, Thomas Rüdiger, Eva Geissinger, Florian Weissinger, Christoph Nerl, Norbert Schmitz, Andreas Engert, Hermann Einsele, Hans Konrad Müller-Hermelink, Martin Wilhelm. J Clin Oncol 2009
283
12

Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements.
Rebecca A Luchtel, Surendra Dasari, Naoki Oishi, Martin Bjerregård Pedersen, Guangzhen Hu, Karen L Rech, Rhett P Ketterling, Jagmohan Sidhu, Xueju Wang, Ryohei Katoh,[...]. Blood 2018
60
20

Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma.
Javeed Iqbal, George Wright, Chao Wang, Andreas Rosenwald, Randy D Gascoyne, Dennis D Weisenburger, Timothy C Greiner, Lynette Smith, Shuangping Guo, Ryan A Wilcox,[...]. Blood 2014
304
12

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial.
H Miles Prince, Youn H Kim, Steven M Horwitz, Reinhard Dummer, Julia Scarisbrick, Pietro Quaglino, Pier Luigi Zinzani, Pascal Wolter, Jose A Sanches, Pablo L Ortiz-Romero,[...]. Lancet 2017
307
11

Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma.
Sonali M Smith, Linda J Burns, Koen van Besien, Jennifer Lerademacher, Wensheng He, Timothy S Fenske, Ritsuro Suzuki, Jack W Hsu, Harry C Schouten, Gregory A Hale,[...]. J Clin Oncol 2013
148
11

Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers.
G Fossard, F Broussais, I Coelho, S Bailly, E Nicolas-Virelizier, E Toussaint, C Lancesseur, F Le Bras, E Willems, E Tchernonog,[...]. Ann Oncol 2018
72
15

Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing.
Andrew L Feldman, Ahmet Dogan, David I Smith, Mark E Law, Stephen M Ansell, Sarah H Johnson, Julie C Porcher, Nazan Ozsan, Eric D Wieben, Bruce W Eckloff,[...]. Blood 2011
194
11

The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study.
Steven I Park, Steven M Horwitz, Francine M Foss, Lauren C Pinter-Brown, Kenneth R Carson, Steven T Rosen, Barbara Pro, Eric D Hsi, Massimo Federico, Christian Gisselbrecht,[...]. Cancer 2019
64
17

Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study.
Andrea Gallamini, Caterina Stelitano, Roberta Calvi, Monica Bellei, Daniele Mattei, Umberto Vitolo, Fortunato Morabito, Maurizio Martelli, Ercole Brusamolino, Emilio Iannitto,[...]. Blood 2004
427
11


ALK+ lymphoma: clinico-pathological findings and outcome.
B Falini, S Pileri, P L Zinzani, A Carbone, V Zagonel, C Wolf-Peeters, G Verhoef, F Menestrina, G Todeschini, M Paulli,[...]. Blood 1999
427
10

Immunohistochemistry as a valuable tool to assess CD30 expression in peripheral T-cell lymphomas: high correlation with mRNA levels.
Céline Bossard, Maria Pamela Dobay, Marie Parrens, Laurence Lamant, Edoardo Missiaglia, Corinne Haioun, Antoine Martin, Bettina Fabiani, Richard Delarue, Olivier Tournilhac,[...]. Blood 2014
68
14

WHO-EORTC classification for cutaneous lymphomas.
Rein Willemze, Elaine S Jaffe, Günter Burg, Lorenzo Cerroni, Emilio Berti, Steven H Swerdlow, Elisabeth Ralfkiaer, Sergio Chimenti, José L Diaz-Perez, Lyn M Duncan,[...]. Blood 2005
10

Revised response criteria for malignant lymphoma.
Bruce D Cheson, Beate Pfistner, Malik E Juweid, Randy D Gascoyne, Lena Specht, Sandra J Horning, Bertrand Coiffier, Richard I Fisher, Anton Hagenbeek, Emanuele Zucca,[...]. J Clin Oncol 2007
10

Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Société Francaise de Greffe de Moëlle et de Thérapie Cellulaire.
Steven Le Gouill, Noel Milpied, Agnès Buzyn, Régis Peffault De Latour, Jean-Paul Vernant, Mohamad Mohty, Marie-Pierre Moles, Krimo Bouabdallah, Claude-Eric Bulabois, Jehan Dupuis,[...]. J Clin Oncol 2008
215
10

Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
F d'Amore, P Gaulard, L Trümper, P Corradini, W-S Kim, L Specht, M Bjerregaard Pedersen, M Ladetto. Ann Oncol 2015
119
10

Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy.
J S Abramson, T Feldman, A R Kroll-Desrosiers, L S Muffly, E Winer, C R Flowers, F Lansigan, C Nabhan, L J Nastoupil, R Nath,[...]. Ann Oncol 2014
100
10

Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma.
Steven M Horwitz, Raphael Koch, Pierluigi Porcu, Yasuhiro Oki, Alison Moskowitz, Megan Perez, Patricia Myskowski, Adam Officer, Jacob D Jaffe, Sara N Morrow,[...]. Blood 2018
150
10

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.
S W Morris, M N Kirstein, M B Valentine, K G Dittmer, D N Shapiro, D L Saltman, A T Look. Science 1994
10

A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma.
Jennifer E Amengual, Renee Lichtenstein, Jennifer Lue, Ahmed Sawas, Changchun Deng, Emily Lichtenstein, Karen Khan, Laine Atkins, Aishling Rada, Hye A Kim,[...]. Blood 2018
69
14

Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95.
Audrey Simon, Michel Peoch, Philippe Casassus, Eric Deconinck, Philippe Colombat, Bernard Desablens, Olivier Tournilhac, Houchingue Eghbali, Charles Foussard, Jerome Jaubert,[...]. Br J Haematol 2010
117
10

Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score.
Philip Went, Claudio Agostinelli, Andrea Gallamini, Pier Paolo Piccaluga, Stefano Ascani, Elena Sabattini, Francesco Bacci, Brunangelo Falini, Teresio Motta, Marco Paulli,[...]. J Clin Oncol 2006
257
9

Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma.
Mark W Clemens, L Jeffrey Medeiros, Charles E Butler, Kelly K Hunt, Michelle A Fanale, Steven Horwitz, Dennis D Weisenburger, Jun Liu, Elizabeth A Morgan, Rashmi Kanagal-Shamanna,[...]. J Clin Oncol 2016
251
9

Five-year outcomes for frontline brentuximab vedotin with CHP for CD30-expressing peripheral T-cell lymphomas.
Michelle A Fanale, Steven M Horwitz, Andres Forero-Torres, Nancy L Bartlett, Ranjana H Advani, Barbara Pro, Robert W Chen, Andrew Davies, Tim Illidge, Mayur Uttarwar,[...]. Blood 2018
43
20

Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network.
Massimo Federico, Monica Bellei, Luigi Marcheselli, Marc Schwartz, Martina Manni, Vittoria Tarantino, Stefano Pileri, Young-Hyeh Ko, Maria E Cabrera, Steven Horwitz,[...]. Br J Haematol 2018
33
27

Diagnostic accuracy of a defined immunophenotypic and molecular genetic approach for peripheral T/NK-cell lymphomas. A North American PTCL study group project.
Eric D Hsi, Jonathan Said, William R Macon, Scott J Rodig, Sarah L Ondrejka, Randy D Gascoyne, Elizabeth A Morgan, David M Dorfman, Matthew J Maurer, Ahmet Dogan. Am J Surg Pathol 2014
30
26


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.